All news

Form SCHEDULE 13G/A Contineum Therapeutics, Filed by: FRANKLIN TEMPLETON INC

Alpha Vantage · StreetInsider · · AI-summarised by FinFlash

Franklin Templeton, Inc. has filed an amended Schedule 13G/A for Contineum Therapeutics, Inc., reporting beneficial ownership of 1,704,550 Class A Common Stock shares, representing 5.2% of the class. The filing also names Charles B. Johnson, Rupert H. Johnson, Jr., and Franklin Advisers, Inc. as reporting persons.

Read original source

BEN company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.